EGFR and colorectal carcinoma: The expression of claudin-3, regulated through N-glycosylation-dependent receptor tyrosine kinase signaling involving EGFR and IGF1R, correlates with CRC malignancy and poor prognosis, especially in CMS2 and CMS3 molecular subtypes [96].